**Core Concept**
Chediak-Higashi syndrome (CHS) is a rare genetic disorder characterized by abnormal lysosome formation and function, leading to impaired phagocytosis and intracellular killing of pathogens.

**Why the Correct Answer is Right**
CHS is caused by mutations in the LYST gene, which encodes a protein involved in the regulation of lysosome formation and trafficking. As a result, phagolysosomes in CHS patients are unable to fuse properly, leading to defective degradation of ingested pathogens. This defect in phagolysosome function impairs the immune response, making CHS patients more susceptible to recurrent infections, particularly with gram-negative bacteria. The impaired phagolysosome function also leads to the accumulation of abnormal lysosomes in various cell types, including neutrophils, macrophages, and platelets.

**Why Each Wrong Option is Incorrect**
**Option B:** Defects in macrophage production are not the primary feature of CHS; while macrophages are indeed affected, the underlying issue is with their function, not their production.
**Option C:** Leukocyte adhesion is not directly impaired in CHS; the issue lies with the intracellular killing of pathogens, not the ability of leukocytes to adhere to endothelial cells.
**Option D:** Defects in microbicidal activity are a consequence of the impaired phagolysosome function in CHS, but they are not the primary defect; the correct answer is more specific to the underlying mechanism.

**Clinical Pearl / High-Yield Fact**
CHS is an autosomal recessive disorder, and patients often present with a history of recurrent infections, particularly with gram-negative bacteria, as well as bleeding tendencies due to platelet dysfunction. A key diagnostic feature is the presence of giant granules in neutrophils and other cell types.

**✓ Correct Answer: A. Defects in phagolysosome function**